diazoxide has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadriu, B | 1 |
| Yuan, S | 1 |
| Farmer, C | 1 |
| Nugent, AC | 1 |
| Lener, MS | 1 |
| Niciu, MJ | 1 |
| Park, M | 1 |
| Yazdian, A | 1 |
| Ballard, ED | 1 |
| Henn, FA | 1 |
| Henter, ID | 1 |
| Park, LT | 1 |
| Zarate, CA | 1 |
1 trial available for diazoxide and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.
Topics: Adult; Aged; Cross-Over Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistan | 2018 |